Cytokinetics Inc Analyst and Investor Day Transcript

Oct 07, 2021 / 12:30PM GMT
Joanna Siegall -

I'm Joanna Siegall, Senior Manager of Corporate Communications and Investor Relations at Cytokinetics. I'm pleased to welcome you to Charting The Commercial Course, our 2021 Analyst and Investor Day.

We are pleased to be hosting this event in a hybrid fashion, and we welcome everyone here in the room as well as everyone attending online. We have a great program for you today, and we look forward to sharing updates on our go-to-market strategy for omecamtiv as well as our cardiovascular pipeline.

Before I continue, please note that portions of the following discussion, including our responses to questions, contain statements that relate to future events and performance rather than historical facts and constitute forward-looking statements. Our actual results might differ materially from those projected in these forward-looking statements. Additional information concerning factors that could cause our actual results to differ materially from those in these forward-looking statements is contained in our SEC filings. We undertake no obligation to update any forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot